Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1192 of 1,261
  1. US 6479498

    Sodium channel drugs and uses

    Theravance, Inc. Β· Granted Nov 12, 2002 Β· Expires Nov 7, 2022

    expired
  2. US 6476017

    Compounds activating pharmacological effect of retinoids

    Institute of Medicinal Molecular Design, Inc. Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  3. US 6476236

    Synthesis of 2-cyanoaziridine-1-carboxamide

    THE ARIZONA BOARD OF REGENTS Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  4. US 6476201

    Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines

    The United States of America as represented by the Secretary of the Army Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  5. US 6476037

    L-arginine and phosphodiesterase (PDE) inhibitor synergism

    The Regents of the University of California Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  6. US 6475985

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  7. US 6475789

    Human telomerase catalytic subunit: diagnostic and therapeutic methods

    The Regents of the University of Technology Office of Technology Transfer Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  8. US 6475724

    Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

    The Regents of the University of California Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  9. US 6475508

    Methods and pharmaceutical compositions for the closure of retinal breaks

    The Regents of the University of California Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  10. US 6475489

    Synthesis of human virus antigens by yeast

    The Regents of the University of California Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  11. US 6475527

    Use of chlorate ion or preparations thereof for reduction of food borne pathogens

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  12. US 6476006

    Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  13. US 6475741

    Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 5, 2002 Β· Expires Oct 31, 2022

    expired
  14. US 2002161051

    (2-hydroxy)ethyl-thioureas useful as modulators of alpha2B adrenergic receptors

    ALLERGAN INC [US] Β· Granted Oct 31, 2002 Β· Expires Oct 26, 2022

    expired
  15. US 6472437

    Active topical skin protectants

    The United States of America as represented by the Secretary of the Army Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  16. US 6472369

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  17. US 6472178

    Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  18. US 6472179

    Receptor based antagonists and methods of making and using

    REGENERON PHARMACEUTICALS, INC. Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  19. US 6471967

    Recombinant intracellular pathogen vaccines and methods for use

    The Regents of the University of California Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  20. US 6471968

    Multifunctional nanodevice platform

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  21. US 6472438

    Active topical skin protectants containing S-330

    The United States of America as represented by the Secretary of the Army Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  22. US 6472197

    GRB2 associating polypeptides and nucleic acids encoding therefor

    The Regents of the University of California Β· Granted Oct 29, 2002 Β· Expires Oct 24, 2022

    expired
  23. US 6468959

    Peroral dosage form for peptide containing medicaments, in particular insulin

    ALFATEC-Pharm GmbH Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  24. US 6469037

    Prophylactic or therapeutic drug for renal diseases

    Takeda Chemical Industries Ltd. Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.